Literature DB >> 8585720

Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime-ciprofloxacin antibiotic combination.

P Brouqui1, M C Rousseau, A Stein, M Drancourt, D Raoult.   

Abstract

Indwelling device infections are associated with considerable morbidity and extremely high cost. Pseudomonas aeruginosa is the most frequent gram-negative etiologic agent associated with infections of indwelling catheters and foreign body implants. It is generally agreed that eradication of infection in the presence of a foreign body requires removal of the foreign body. Using a combination of ceftazidime and ciprofloxacin, we cured nine of nine patients with P. aeruginosa-infected osteosynthetic material and four of five patients with hip and knee prostheses without removing the foreign material. Follow-up was for a mean of 21 months (range, 6 to 60 months). Some patients experienced minor side effects (arthralgia in one patient and rash in another patient). We conclude that this combination is effective and safe and should be useful in the treatment of P. aeruginosa-infected orthopedic implants.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8585720      PMCID: PMC162959          DOI: 10.1128/AAC.39.11.2423

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Deep wound sepsis following total hip arthroplasty.

Authors:  R H Fitzgerald; D R Nolan; D M Ilstrup; R E Van Scoy; J A Washington; M B Coventry
Journal:  J Bone Joint Surg Am       Date:  1977-10       Impact factor: 5.284

Review 2.  Problems associated with the infected total hip arthroplasty.

Authors:  R H Fitzgerald
Journal:  Clin Rheum Dis       Date:  1986-08

3.  Reimplantation for the salvage of an infected total knee arthroplasty.

Authors:  J A Rand; R S Bryan
Journal:  J Bone Joint Surg Am       Date:  1983-10       Impact factor: 5.284

4.  Treatment of skin, skin structure, bone, and joint infections with ceftazidime.

Authors:  L O Gentry
Journal:  Am J Med       Date:  1985-08-09       Impact factor: 4.965

5.  Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants.

Authors:  M Drancourt; A Stein; J N Argenson; A Zannier; G Curvale; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

6.  Infection rates after 3175 total hip and total knee replacements performed with and without a horizontal unidirectional filtered air-flow system.

Authors:  E A Salvati; R P Robinson; S M Zeno; B L Koslin; B D Brause; P D Wilson
Journal:  J Bone Joint Surg Am       Date:  1982-04       Impact factor: 5.284

7.  Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokinetics.

Authors:  D E Nix; T J Cumbo; P Kuritzky; J M DeVito; J J Schentag
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

8.  [Value of the technique of cellular lysis by thermic shock in the isolation of bacteria causing osteoarticular infections].

Authors:  A Zannier; M Drancourt; J P Franceschi; J M Aubaniac; D Raoult
Journal:  Pathol Biol (Paris)       Date:  1991-05

9.  Two-stage reimplantation for the salvage of infected total knee arthroplasty.

Authors:  J N Insall; F M Thompson; B D Brause
Journal:  J Bone Joint Surg Am       Date:  1983-10       Impact factor: 5.284

10.  Clinical and microbial features of prosthetic joint infection.

Authors:  R D Inman; K V Gallegos; B D Brause; P B Redecha; C L Christian
Journal:  Am J Med       Date:  1984-07       Impact factor: 4.965

View more
  22 in total

1.  Corynebacterium species isolated from bone and joint infections identified by 16S rRNA gene sequence analysis.

Authors:  Véronique Roux; Michel Drancourt; Andreas Stein; Philippe Riegel; Didier Raoult; Bernard La Scola
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

2.  Antibiotic resistance in orthopaedic surgery: acute knee prosthetic joint infections due to extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae.

Authors:  J C Martínez-Pastor; F Vilchez; C Pitart; J M Sierra; A Soriano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-15       Impact factor: 3.267

3.  First case of osteomyelitis due to Shewanella algae.

Authors:  E Botelho-Nevers; F Gouriet; C Rovery; P Paris; V Roux; D Raoult; P Brouqui
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Remission after treatment of osteoarticular infections due to Pseudomonas aeruginosa versus Staphylococcus aureus: a case-controlled study.

Authors:  Khalid Seghrouchni; Christian van Delden; Dennis Dominguez; Mohamed Benkabouche; Louis Bernard; Mathieu Assal; Pierre Hoffmeyer; Ilker Uçkay
Journal:  Int Orthop       Date:  2011-10-05       Impact factor: 3.075

5.  Bacteriophage delivering hydrogels reduce biofilm formation in vitro and infection in vivo.

Authors:  James A Wroe; Christopher T Johnson; Andrés J García
Journal:  J Biomed Mater Res A       Date:  2019-09-05       Impact factor: 4.396

6.  Biocompatible nano-gallium/hydroxyapatite nanocomposite with antimicrobial activity.

Authors:  Mario Kurtjak; Marija Vukomanović; Lovro Kramer; Danilo Suvorov
Journal:  J Mater Sci Mater Med       Date:  2016-10-04       Impact factor: 3.896

Review 7.  Use of quinolones in osteomyelitis and infected orthopaedic prosthesis.

Authors:  D P Lew; F A Waldvogel
Journal:  Drugs       Date:  1999       Impact factor: 9.546

8.  Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes.

Authors:  Maria Van Gennip; Louise Dahl Christensen; Morten Alhede; Richard Phipps; Peter Østrup Jensen; Lars Christophersen; Sünje Johanna Pamp; Claus Moser; Per Jensen Mikkelsen; Andrew Y Koh; Tim Tolker-Nielsen; Gerald B Pier; Niels Høiby; Michael Givskov; Thomas Bjarnsholt
Journal:  APMIS       Date:  2009-07       Impact factor: 3.205

9.  Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole).

Authors:  A Stein; J F Bataille; M Drancourt; G Curvale; J N Argenson; P Groulier; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

10.  Outcome of acute prosthetic joint infections due to gram-negative bacilli treated with open debridement and retention of the prosthesis.

Authors:  Juan C Martínez-Pastor; Ernesto Muñoz-Mahamud; Félix Vilchez; Sebastián García-Ramiro; Guillem Bori; Josep Sierra; José A Martínez; Lluis Font; Josep Mensa; Alex Soriano
Journal:  Antimicrob Agents Chemother       Date:  2009-08-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.